Whether you require support in one area of your medical device development program, or throughout the entire process, NAMSA has the expertise and capabilities to equip you with the resources you need, when you need them.
From concept to post-market, NAMSA’s Product Development Strategy (PDS) service offering provides proven solutions to assist clients with any development challenge, therapeutic area, reimbursement issue or regulatory environment. The PDS Team, comprised of cross-functional scientists and strategists who can support a multitude of medical devices, In Vitro Diagnostic (IVD) or drug/device combination programs, provides manufacturers a “next steps” strategy within any stage of the development continuum.
- A start-up firm with limited resources and funds?
- Unable to leverage the knowledge your team gains on preclinical studies to apply to your overall strategy?
- Concerned with the time required to hire and train staff, but need the expertise today?
- Looking for ways to reduce total development timelines and costs, and lessen burn rates prior to commercialization?
Serving as an extension of your internal team, our PDS experts understand how to align all stakeholders to proactively address development barriers and reduce risks. They serve as a guiding authority on how to most efficiently navigate intended global markets to safely and efficaciously get to market quickly, while saving you time and money.
Image: NAMSA understands the importance of aligning all product development stakeholders from the start.